These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 19022817)

  • 1. Progressive multifocal leucoencephalopathy in the rheumatic diseases: assessing the risks of biological immunosuppressive therapies.
    Calabrese LH; Molloy ES
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii64-5. PubMed ID: 19022817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk?
    Molloy ES; Calabrese LH
    Autoimmun Rev; 2008 Dec; 8(2):144-6. PubMed ID: 18700172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: evolving role of biologic therapies.
    Molloy ES; Calabrese LH
    Arthritis Rheum; 2012 Sep; 64(9):3043-51. PubMed ID: 22422012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progressive multifocal leukoencephalopathy as a result of immunosuppressive therapy].
    Arbusow V; Strupp M; Samtleben W; Hatz H; Brückmann H; Brandt T
    Dtsch Med Wochenschr; 1999 May; 124(21):653-6. PubMed ID: 10382545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Risk of Progressive Multifocal Leukoencephalopathy in the Biologic Era: Prevention and Management.
    Molloy ES; Calabrese CM; Calabrese LH
    Rheum Dis Clin North Am; 2017 Feb; 43(1):95-109. PubMed ID: 27890176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases.
    Molloy ES; Calabrese LH
    Arthritis Rheum; 2009 Dec; 60(12):3761-5. PubMed ID: 19950261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases.
    Boren EJ; Cheema GS; Naguwa SM; Ansari AA; Gershwin ME
    J Autoimmun; 2008; 30(1-2):90-8. PubMed ID: 18191544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive multifocal leukoencephalopathy.
    Aksamit AJ
    Continuum (Minneap Minn); 2012 Dec; 18(6 Infectious Disease):1374-91. PubMed ID: 23221846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of progressive multifocal leukoencephalopathy and natalizumab.
    Aksamit AJ
    Neurologist; 2006 Nov; 12(6):293-8. PubMed ID: 17122725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progressive multifocal leukoencephalopathy in a patient following long-term immunosuppressive therapy for systemic lupus erythematosus].
    Kappers MH; Swaak AJ; Zuidgeest DM; Dees A
    Ned Tijdschr Geneeskd; 2006 Feb; 150(7):387-92. PubMed ID: 16523804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JC viral loads in patients with Crohn's disease treated with immunosuppression: can we screen for elevated risk of progressive multifocal leukoencephalopathy?
    Verbeeck J; Van Assche G; Ryding J; Wollants E; Rans K; Vermeire S; Pourkarim MR; Noman M; Dillner J; Van Ranst M; Rutgeerts P
    Gut; 2008 Oct; 57(10):1393-7. PubMed ID: 18436577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monoclonal antibodies in multiple sclerosis].
    Papeix C; Lubetzki C
    Med Sci (Paris); 2009 Dec; 25(12):1113-5. PubMed ID: 20035688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive multifocal leucoencephalopathy associated with lupus and methotrexate overdose.
    Shprecher D; Frech T; Chin S; Eskandari R; Steffens J
    Lupus; 2008 Nov; 17(11):1029-32. PubMed ID: 18852228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of cytomegalovirus infection in rheumatic diseases: multicentre survey in a large patient population.
    Takizawa Y; Inokuma S; Tanaka Y; Saito K; Atsumi T; Hirakata M; Kameda H; Hirohata S; Kondo H; Kumagai S; Tanaka Y
    Rheumatology (Oxford); 2008 Sep; 47(9):1373-8. PubMed ID: 18577548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PML and rheumatology: the contribution of disease and drugs.
    Molloy ES
    Cleve Clin J Med; 2011 Nov; 78 Suppl 2():S28-32. PubMed ID: 22123931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive multifocal leukoencephalopathy and antipsoriatic drugs: assessing the risk of immunosuppressive treatments.
    Di Lernia V
    Int J Dermatol; 2010 Jun; 49(6):631-5. PubMed ID: 20618466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive multifocal leukoencephalopathy - the importance of early diagnosis illustrated in four cases.
    Nived O; Bengtsson AA; Jönsen A; Sturfelt G
    Lupus; 2008 Nov; 17(11):1036-41. PubMed ID: 18852230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies.
    Tavazzi E; Ferrante P; Khalili K
    Clin Microbiol Infect; 2011 Dec; 17(12):1776-80. PubMed ID: 22082208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorting out the risks in progressive multifocal leukoencephalopathy.
    Calabrese LH; Molloy E; Berger J
    Nat Rev Rheumatol; 2015 Feb; 11(2):119-23. PubMed ID: 25314016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progressive Multifocal Leukoencephalopathy in Systemic Lupus Erythematosus].
    Yukitake M
    Brain Nerve; 2019 May; 71(5):493-505. PubMed ID: 31088998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.